|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2004-5-13
|
|
pubmed:abstractText |
To assess the efficacy and survival benefit of low-dose fluconazole (400 mg weekly) for primary prophylaxis for cryptococcal meningitis in patients with advanced HIV infection.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1464-2662
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
5
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
140-3
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15139978-AIDS-Related Opportunistic Infections,
pubmed-meshheading:15139978-Adult,
pubmed-meshheading:15139978-Aged,
pubmed-meshheading:15139978-Antifungal Agents,
pubmed-meshheading:15139978-Double-Blind Method,
pubmed-meshheading:15139978-Female,
pubmed-meshheading:15139978-Fluconazole,
pubmed-meshheading:15139978-Humans,
pubmed-meshheading:15139978-Male,
pubmed-meshheading:15139978-Meningitis, Cryptococcal,
pubmed-meshheading:15139978-Middle Aged,
pubmed-meshheading:15139978-Prospective Studies,
pubmed-meshheading:15139978-Survival Analysis,
pubmed-meshheading:15139978-Treatment Outcome
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
A multicentre, randomized, double-blind, placebo-controlled trial of primary cryptococcal meningitis prophylaxis in HIV-infected patients with severe immune deficiency.
|
|
pubmed:affiliation |
Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand. ploencha@kku.ac.th
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
